# Georgia Center for Diabetes Translation Research

> **NIH NIH P30** · EMORY UNIVERSITY · 2022 · $796,968

## Abstract

OVERVIEW: PROJECT SUMMARY / ABSTRACT
While considerable evidence is available for prevention and care of diabetes, huge gaps remain in equitable
and sustainable translation of this knowledge into practice and policy in clinical and community settings. To
close these gaps, the Georgia Center for Diabetes Translation Research (GCDTR), has leveraged the
multidisciplinary expertise and experience in Atlanta, by bringing together collaborations among researchers
from several leading institutions, namely, Emory's Rollins School of Public Health, School of Medicine, School
of Nursing, and Goizueta Business School; Georgia Institute of Technology; and Morehouse School of
Medicine. Having successfully expanded the translation research (from $15 to $33 million annually), and
investigators (from 38 to 102 members, including 26 newly recruited diabetes faculty) bases, GCDTR will
embrace the vision of equity and strive to close the gaps in diabetes prevention and care across demographic
and comorbid groups, especially in socially, economically, and ethnically disadvantaged populations. GCDTR
will include an Administrative Core A, seamlessly coordinating three interconnected translation research cores:
(1) Core B, Design and Evaluation for Equity, emphasizing measurement and learning from previous
experiences—both successes and failures—through appropriate metrics and evaluation and innovating for the
future (design) to help stimulate progress; (2) Core C, Socio-ecological and Behavioral Sciences for Equity,
bringing a wealth of interdisciplinary experiences in developing theoretically-based interventions and
innovative, technology-driven engagement methodologies promoting the adoption and maintenance of health-
promoting behaviors among vulnerable populations; and (3) a Regional Core, Technologies Advancing
Translation and Equity, and expanding partnerships to include institution in neighboring Florida and Tennessee
– southeastern states that have historically had large underserved areas and populations at high risk for
diabetes. Enrichment and Pilot and Feasibility Programs will continue to enhance young and transitioning
investigators' capacity to be competitive for NIH funds in translation research and have impact on diabetes
prevention and care. This multi-institutional, multidisciplinary center, involving over 120 members, brings
considerable breadth and depth of research expertise, a substantial research base, and leverages several
NIH-funded Centers, namely, the Georgia Clinical and Translational Science Alliance (GaCTSA), Center for
AIDS Research (CFAR), and the AHA-funded Morehouse/Emory Center for Health Equity. Proximity to and
relationships with the Division of Diabetes Translation at the US Centers for Disease Control and Prevention
(CDC) also offers GCDTR many unique assets. Furthermore, we have instituted several innovations, and
obtained strong institutional support and commitments (totaling $857,500 over 5 years), and leveraged a
variety of d...

## Key facts

- **NIH application ID:** 10470276
- **Project number:** 5P30DK111024-07
- **Recipient organization:** EMORY UNIVERSITY
- **Principal Investigator:** Kabayam M Venkat Narayan
- **Activity code:** P30 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2022
- **Award amount:** $796,968
- **Award type:** 5
- **Project period:** 2016-09-16 → 2026-07-31

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10470276

## Citation

> US National Institutes of Health, RePORTER application 10470276, Georgia Center for Diabetes Translation Research (5P30DK111024-07). Retrieved via AI Analytics 2026-05-22 from https://api.ai-analytics.org/grant/nih/10470276. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*